BIOMAT Database Logo BIOMAT Database Logo

Serum TAG 72 levels in different human carcinomas. 1991

M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
Clinical Chemistry Laboratory, RIA Unit, Oncology Institute of Bari, Italy.

Since December 1988, we have measured the TAG 72 serum levels in 326 patients with different carcinomas, especially breast, gastrointestinal and ovarian, using a RIA kit. With a cut-off value of 5 U/mL, a specificity of 100% in the controls and an overall sensitivity of 22% in the neoplastic patients was obtained, with the highest positivities in ovarian (63%) and gastric (58%) carcinomas. Therefore, TAG 72 can be associated with other tumor markers for these latter neoplasms.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
Serum levels of tumor-associated glycoprotein (TAG-72) in digestive cancers.
January 1990, Oncology,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.
July 1990, British journal of cancer,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinoma.
January 1996, The International journal of biological markers,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
Clinical significance of preoperative serum levels of CA 125 and TAG-72 in ovarian carcinoma.
January 1997, The International journal of biological markers,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
TAG-72 serum determination in early and advanced gastric cancer.
August 1989, International journal of cancer,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
TAG-72 in gastric cancer: relationship between preoperative serum levels and tumoral content of the antigen.
January 2000, The International journal of biological markers,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
June 1986, Journal of the National Cancer Institute,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.
January 1992, Bulletin du cancer,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas.
January 2001, Oncology reports,
M Correale, and I Abbate, and G Gargano, and M Garrubba, and A Muncipinto, and L Addabbo, and D Colangelo
[The value of serum tumor-associated glycoprotein 72 (TAG 72) in the diagnosis of malignancies].
December 1992, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Copied contents to your clipboard!